Evogene Schedules Second Quarter 2025 Financial Results Release

Rhea-AI Summary

Evogene (NASDAQ: EVGN), a computational biology company focused on life-science product discovery and development, has scheduled its Q2 2025 financial results release for Tuesday, August 19, 2025. The company will host a conference call to discuss the results at 9:00 AM ET (4:00 PM Israel time).

Interested participants must register in advance through the company's dedicated conference link. A recording of the conference will be made available on Evogene's website following the event.

Zoom conference call scheduled for August 19, 2025, 9:00 AM ET

REHOVOT, Israel, July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday, August 19, 2025.

 

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To attend the conference, please register in advance:

https://www.veidan-conferencing.com/evogene

The entire conference will be available online on the company's website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its subsidiaries, including:

1. Biomica Ltd. (www.biomicamed.com) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
   
   
2. Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
   
   
3. AgPlenus Ltd. (www.agplenus.com) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
   
   
4. Casterra Ag Ltd. (www.casterra.co) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Contact:
ir@evogene.com
Tel: +972-8-9311901

Logo: https://mma.prnewswire.com/media/1947468/4576969/Evogene_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2025-financial-results-release-302515858.html

SOURCE Evogene

FAQ

When will Evogene (EVGN) release its Q2 2025 financial results?

Evogene will release its Q2 2025 financial results on Tuesday, August 19, 2025.

What time is Evogene's Q2 2025 earnings conference call?

Evogene's Q2 2025 earnings conference call is scheduled for 9:00 AM Eastern Time (4:00 PM Israel time) on August 19, 2025.

How can investors join Evogene's Q2 2025 earnings call?

Investors must register in advance through the dedicated conference link at www.veidan-conferencing.com/evogene.

Where can I find a replay of Evogene's Q2 2025 earnings call?

A recording of the conference call will be available on Evogene's website a few days after the event.